Mao Zhang

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 4

Top Topics

Lymph Node Metastasis

Cardiovascular Disease

Atrial Fibrillation

Top Venues

Oxidative medicine and cellular longevity

Circulation research

Nature cardiovascular research

This page only lists publications with an associated author ORCID identifier.

Publications

Chun Liu, Mengcheng Shen, Wilson L W Tan, Ian Y Chen, Yu Liu, Xuan Yu, Huaxiao Yang, Angela Zhang, Yanxia Liu, Ming-Tao Zhao, Mohamed Ameen, Mao Zhang, Eric R Gross, Lei S Qi, Nazish Sayed, Joseph C Wu
Statins improve endothelial function via suppression of epigenetic-driven EndMT. Nature cardiovascular research 2 (5) (2023)
Junxia Zhang, Ruqi Liang, Kai Wang, Wenjia Zhang, Mao Zhang, Li Jin, Peng Xie, Wen Zheng, Haibao Shang, Qingmei Hu, Jiayi Li, Gengjia Chen, Fujian Wu, Feng Lan, Lipeng Wang, Shi-Qiang Wang, Yongfeng Li, Yong Zhang, Jinghao Liu, Fengxiang Lv, Xinli Hu, Rui-Ping Xiao, Xiaoguang Lei, Yan Zhang
Novel CaMKII-δ Inhibitor Hesperadin Exerts Dual Functions to Ameliorate Cardiac Ischemia/Reperfusion Injury and Inhibit Tumor Growth. Circulation 145 (15) (2022)
Yuan Yao, Fan Li, Mao Zhang, Li Jin, Peng Xie, Dairu Liu, Junxia Zhang, Xinli Hu, Fengxiang Lv, Haibao Shang, Wen Zheng, Xueting Sun, Jiaxin Duanmu, Fujian Wu, Feng Lan, Rui-Ping Xiao, Yan Zhang
Targeting CaMKII-δ9 Ameliorates Cardiac Ischemia/Reperfusion Injury by Inhibiting Myocardial Inflammation. Circulation research 130 (6) (2022)
Changpei Xiang, Fangbo Zhang, Jinhuan Gao, Feifei Guo, Mao Zhang, Rui Zhou, Junying Wei, Ping Wang, Yi Zhang, Jingjing Zhang, Hongjun Yang
Yixin-Shu Capsules Ameliorated Ischemia-Induced Heart Failure by Restoring Trx2 and Inhibiting JNK/p38 Activation. Oxidative medicine and cellular longevity 2021 (2021)